You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 24, 2025

Patent: 10,047,163


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,047,163
Title:Multispecific constructs
Abstract: Provided are novel multispecific antibody constructs and multispecific antibody drug conjugates (ADCs), and methods of using such antibodies and ADCs to treat cancer. IgG-like bispecific antibodies have different binding specificities on each arm of the antibody. They are similar in structure to monospecific IgGs in that they contain two heavy chains with VH, CH1, CH2 and CH3 regions, and two light chains with VL and CL regions.
Inventor(s): Liu; David (San Francisco, CA)
Assignee: AbbVie Stemcentrx LLC (North Chicago, IL)
Application Number:14/765,861
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,047,163

Introduction

When analyzing a patent, particularly one like United States Patent 10,047,163, it is crucial to delve into the specifics of the claims, the broader patent landscape, and the legal and technological contexts in which the patent operates. This analysis will help in understanding the patent's validity, its potential impact, and its place within the innovative ecosystem.

Understanding Patent-Eligible Subject Matter

To begin, it is essential to understand what constitutes patent-eligible subject matter. Section 101 of the Patent Act (35 U.S.C. §101) defines patentable inventions as "any new and useful process, machine, manufacture, or composition of matter"[1].

Judicially Developed Exceptions

The Supreme Court has established implicit exceptions to patent-eligible subject matter, including "laws of nature, natural phenomena, and abstract ideas" when claimed as such. These exceptions have been refined over time, particularly in recent Supreme Court decisions such as Bilski v. Kappos and Mayo Collaborative Servs. v. Prometheus Labs.[1]

The Alice/Mayo Test

The Alice/Mayo test is a two-step framework used to determine whether a patent claim is directed to an ineligible concept. First, it must be determined if the claim is directed to an abstract idea, law of nature, or natural phenomenon. If so, the second step involves assessing whether the claim contains an inventive concept that transforms the nature of the claim into a patent-eligible application of the ineligible concept[1].

Application to US Patent 10,047,163

To analyze the claims of US Patent 10,047,163, one must apply the Alice/Mayo test. If the claims are directed to an abstract idea or other ineligible concept, they must contain additional elements that provide an inventive concept beyond the ineligible subject matter.

Patent Claims Analysis

Claim Structure and Scope

Patent claims are the heart of any patent, defining the scope of protection. For US Patent 10,047,163, each claim must be examined to determine its hierarchy and relationship to other claims. Tools like the Patent Matrix software can facilitate this analysis by importing, parsing, and displaying claims in a hierarchical and interactive format[2].

Prior Art and Novelty

Conducting prior art searches is critical to ensure the novelty and non-obviousness of the invention. This involves identifying existing technologies or innovations that may affect the validity or patentability of the new invention. Effective patent analysis can help identify relevant prior art, which is crucial for the success of the patent application[3].

Patent Landscape and Market Impact

Competitive Landscape

Analyzing the patent landscape helps businesses understand the competitive environment and barriers to entry. This includes identifying white spaces or areas with fewer patents, indicating potential opportunities for innovation. By examining the citations and patent families related to US Patent 10,047,163, one can gauge its importance within the technological field and its potential market impact[3].

Technology Trends and R&D Strategy

Patent analysis can refine R&D strategies by identifying trends and gaps in the technology field. This helps organizations make informed decisions about where to focus their research and development efforts. For US Patent 10,047,163, understanding the broader technology trends can provide insights into its potential for commercialization and market dominance[3].

Legal and Regulatory Compliance

Patent Term and Expiration

The term of a patent, typically twenty years from the filing date, is crucial for understanding its lifespan and the period during which it can be enforced. For patents like US 10,047,163, any terminal disclaimers or continuations can affect the patent term, and it is essential to calculate the exact expiration date based on the relevant provisions of the Patent Act[4].

Litigation and Enforcement

The enforceability of a patent is not just about its validity but also about its ability to withstand legal challenges. The 2019 Guidance from the USPTO, while not binding on courts, has clarified how to apply the Alice/Mayo framework, potentially affecting the litigation landscape for patents like US 10,047,163[1].

Stakeholder Views and Legislative Developments

Recent Legislative Proposals

Proposals like the Patent Eligibility Restoration Act of 2023 (PERA 2023) aim to reform the standards for determining patent-eligible subject matter. These proposals could significantly impact the patentability of inventions, especially in emerging technology sectors, and may affect the validity and enforceability of patents like US 10,047,163[1].

Industry Impact

Stakeholders have varying views on the current patent eligibility framework, with some arguing it hinders innovation and others seeing it as necessary to prevent overbroad patent claims. The impact of these views and any legislative changes on the patent landscape and the specific patent in question must be carefully considered[1].

Valuation of Intellectual Property

Licensing and Mergers

The value of a patent like US 10,047,163 is often assessed for licensing, mergers, and acquisitions. Patent analysis provides essential insights into the strength and potential enforceability of the patent, which are critical for negotiations with investors or partners[3].

Technology Transfer and Commercialization

From Research to Market

Patent analysis facilitates the identification of technologies with commercial potential, aiding in the transfer of knowledge and technologies from research settings to the marketplace. For US Patent 10,047,163, understanding its commercial potential involves analyzing its claims, the competitive landscape, and the broader technological trends[3].

Citation Analysis and Patent Family

Understanding Influence and Geographical Coverage

Citation analysis helps gauge the importance of a patent within a technological field. Analyzing the patent family of US 10,047,163 provides insights into its geographical coverage and whether it has been filed in multiple countries, which can be crucial for global market strategies[3].

Key Takeaways

  • Patent-Eligible Subject Matter: Understanding the types of inventions that can be patented under Section 101 of the Patent Act is crucial.
  • Alice/Mayo Test: Applying this test is essential to determine if the claims of US Patent 10,047,163 are directed to an ineligible concept and if they contain an inventive concept.
  • Prior Art and Novelty: Conducting thorough prior art searches is vital for ensuring the novelty and non-obviousness of the invention.
  • Patent Landscape: Analyzing the competitive landscape and technology trends helps in understanding the market impact and potential commercialization of the patent.
  • Legal and Regulatory Compliance: Ensuring compliance with patent term provisions and being aware of legislative developments is critical for the enforceability and validity of the patent.

FAQs

What is the significance of Section 101 of the Patent Act in determining patent-eligible subject matter?

Section 101 of the Patent Act defines what types of inventions can be patented, including processes, machines, manufactures, and compositions of matter. It sets the foundation for what is considered patentable under U.S. law.

How does the Alice/Mayo test impact the patentability of software and biotechnology inventions?

The Alice/Mayo test is a two-step framework that determines if a patent claim is directed to an abstract idea or other ineligible concept. If so, it must contain an inventive concept to be patentable. This test has narrowed the scope of patent-eligible subject matter, particularly affecting software and biotechnology inventions.

What role does prior art play in the patent application process?

Prior art refers to existing technologies or innovations that may affect the validity or patentability of a new invention. Conducting prior art searches is essential to ensure the novelty and non-obviousness of the invention, which is crucial for the success of the patent application.

How does patent analysis help in R&D strategy and technology transfer?

Patent analysis helps organizations refine their R&D strategies by identifying trends and gaps in the technology field. It also facilitates the identification of technologies with commercial potential, aiding in the transfer of knowledge and technologies from research settings to the marketplace.

What are the implications of legislative proposals like PERA 2023 on patent eligibility?

Proposals like PERA 2023 aim to reform the standards for determining patent-eligible subject matter. These reforms could significantly impact the patentability of inventions, especially in emerging technology sectors, and may affect the validity and enforceability of existing patents.

Sources

  1. CRS Reports: "Patent-Eligible Subject Matter Reform: An Overview" (January 3, 2024)
  2. Google Patents: "US20110138338A1 - Patent Claims Analysis System and Method"
  3. Evalueserve: "Patent Analysis"
  4. USPTO: "2701-Patent Term - MPEP"

More… ↓

⤷  Try for Free

Details for Patent 10,047,163

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Genentech, Inc. RITUXAN rituximab Injection 103705 November 26, 1997 10,047,163 2033-02-08
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 September 25, 1998 10,047,163 2033-02-08
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 February 10, 2017 10,047,163 2033-02-08
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 May 07, 2001 10,047,163 2033-02-08
Genzyme Corporation LEMTRADA alemtuzumab Injection 103948 November 14, 2014 10,047,163 2033-02-08
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.